Anemia de los procesos crónicos. Aspectos clínicos y de laboratorio

Revista Cubana de Hematologia, Inmunologia y Hemoterapia

Volumn 18, Issue 3, 2002, Pages

  Barrios, Mariela Forrellat ^a   Delgado, Norma Fernández ^a  

^a INSTITUTO DE HEMATOLOGÍA E INMUNOLOGÍA   (Cuba)

Author keywords

Anemia therapy; Cronic disease therapy; Diagnosis, differential; Ferritin; Homeostasis; Iron; Iron metabolism disorders physiopathology

Indexed keywords

EID: 52649149187     PISSN: 08640289     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Weiss G. Iron and of chronic disease. Kidney Int 1999; 55(Suppl 69): 12-7.
2. Cartright GE, Wintrobe MM. The anemia of infection. Adv Intern Med 1952; 5: 165-70.
3. Erslev A. Anemia of chronic disease. En: Beutler E, Lichtman MA, Cooller BS, Kipps TJ, eds. Williams Hematology . 5th ed. New York: Mc Graw- Hill; 1995.p. 518-24.
4. Means RT, Krantz SB. Progress in understanding the pathogenesis of the anemia of chronic disease. Blood 1992; 80: 1639-47.
5. Fitzimons EJ, Brock JH. The anemia of chronic disease. BMJ 2001; 322: 811-2
6. Cartwright GE. The anemia of chronic disorders. Semin Hematol 1966; 3: 351-4.
7. Means RT. The anemia of chronic disorders. En: Lee GR, Foerster J, Lukens J, Paraskevas F, Green JP, Rodgers CM. Wintrobe's Clinical Hematology. 10th ed. Baltimore: Williams and Wilkins; 1998.p. 1011-21.
8. Robert T, Means Jr. The anaemia of infecction. Bailliere Clin Haematol 2000; 13:151-62.
9. Ludwing H, Fritz E. Anemia in cancer patients. Semin Oncol 1998; 25 (3): 2-6.
10. Means RT. Advances in the anemia chronic disease. Int J Hematol 1999; 70: 7-12.
11. Lau SM, Yu WL, Chow KC, Wang JH. Parvovirus B 19 infection in a human immunodeficiency virus - infected patient with anemia. J Formos Med Assoc 2000; 99: 162-5.
12. Evans RH, Scadden DT. Haematological aspect of HIV infection. Baillieres Clin Haematol 2000; 13 (2): 215-30.
13. Macroft A, Kirk O, Barton SE. Anaemia is an independent predective marker for clinical prognosis in HIV infected patients from across Europe. AISD 1999; 13: 943-50.
14. Cartwright GE, Lee GR. The anaemia of chronic disorders. Br J Haematol 1971; 21: 147-52.
15. Lee MH, Means RT. Extremely elevated serum ferritin levels in a university hospital: associated diseases and clinical significance. Am J Med 1995; 98: 566-71.
16. Dall DC, Weiss RB. Neoplasia and the erythron. J Clin Oncol 1985; 3: 429-33.
17. Jacobs A. Serum ferritin and iron stores. Fed Proc 1997; 36: 2024-27.
18. Baiton DF, Finch CA. The diagnosis of deficiency anemia. Am J Med 1964; 37: 62-8.
19. Konijn AM, Hershko C. The anemia of inflammation and chronic disease. En: De Sousa M, Brock JA. Iron, immunity, cancer and inflammation. Chicjhester: John Wiley; 1989. p. 111-43.
20. Sears DA. Anemia of chronic disease. Med Clin North Am 1992; 76: 567-9.
21. Birgegard G, Hellgän R, Killander A, Strömberg A, Wide L. Serum ferritin during infection. Scand J Hematol 1978; 21: 333-40.
22. Ten CJ, Wolthuis A, Westerhuis B, van Densen C. The iron content of serum ferritin: physiolgical importance and diagnostic value. Eur J Clin Chem Clin Biochem 1997; 35: 53-6.
23. Hann HWL, Stahlhult MW, Millman I. Human ferritins present in the sera of nude mice transplanted with human neuroblastoma or hepatocellularr carcinoma. Cancer Res 1984; 44: 3898-3901.
24. Baynes R, Bezwoda W, Bothwell TH, Khan Q, Mansoor N. The non-immune inflammatory response: serial changes in plasma iron, iron-binding capacity, lactoferrin, ferrintin and C-reactive protein. Scand J Clin Lab Invest 1986; 46: 695-704.
25. Cash JM, Sears DA. The spectrum of disease associated with the anemia of crhonic disease. A study of 90 cases. Am J Med 1990; 87: 638-40.
26. Baer AN, Dessypris EN, Krantz SB. The pathogenesis of anemia in rheumatoid arthritis. A clinical and laboratory analysis. Semin Arthritis Rheum 1990; 14: 209-23.
27. Kuiper-Kramer EP, Huisman CM, van Raan J, van Eijk HG. Analytical and clinical implication of soluble trasferrin receptor in serum. Eur J Clin Biochem 1996; 34: 645-9.
28. Miller A, Chodos RB, Emerson CP, Ross JF. Studies of anemia and iron metbolism in cancer. J Clin Invest 1956; 35: 1248-53.
29. Hyman GA, Harvey JE. The pathogenesis of anemia patients with carcinoma. Am J Med 1995: 350-5.
30. Kohgo Y, Nitsu Y, Kondo H, Kato J, Tsushima N, Sasaki K, et al. Serum transferrin receptor as a new index of erythropoiesis. Blood 1987; 70: 1995-8.
31. Beguin Y, Clemens GK, Pootrakul P, Fillet G. Quantitative assessment of erythropoiesis and functional classification of anemia based on measurements of serum transferrin receptor and erythropoietin. Blood 1993; 81: 1067-76.
32. Vernet M. The transferrin receptor: its role in iron metabolism and its diagnosis utility. Ann Biol Clin 1999; 57: 9-18.
33. Kaltwasser JP, Gottchalk R. Erythropoietin and iron. Kidney Int 1999; 55 (Suppl 69): 49-56.
34. Punnoven K, Irjala K, Rajamaki A. Serum transferrin receptor and its ratio to serum ferritin in diagnosis of iron deficiency. Blood 1997; 89: 1052-7.
35. Means RT, Allen J, Seurs DA, Shuster SJ. Serum soluble receptor and the prediction of marrow aspirate results in a heterogeneous group of patients. Clin Haematol 1999; 21: 161-8.
36. Ferguson BJ, Skikne BS, Simpson KM, Baynes RD, Cook JD. Serum transferring receptor distinguishes the anemia of chronic disease from iron deficiency anemia. J Lab Clin Med 1992, 119: 385-90.
37. Nielsen OJ, Andersen LS, Hansen NE, Hansen TM. Serum transferrin receptor levels in anaemic patients with rheumatoid arthritis. Scan J Clin Lab Invest 1994; 54: 75-82.
38. Kivivouri SM, Pelkoneen P, Ylijoki H, Verronen P, Siimes MA. Elevated serum transferrin receptor concentration in children with juvenil chronic arthritis as evidence of iron deficiency. Rheumatology 2000; 39: 193-7.
39. Teppo AM, Maury CPJ. Radioimmunoassay of tumor necrosis factor in serum. Clin Chem 1987; 33: 2024-8.
40. Skikne BS, Lowers CH, Cook JD. Serum transferrin receptor: a quantitative measure of tissue iron deficiency. Blood 1990; 75: 1870-6.
41. Petterson T, Kiovivuori SM, Siimes MA. Is serum transferrin receptor uselful for detecting iron deficiency in anemic patients with chronic inflammatory disease? Br J Rheumatol 1994; 33: 740-4.
42. Noe G, Augustin J, Hansdorf S, Rich IN, Kubarek B. Serum erythropoietin and transferrin receptor levels in patients with rheumatoid artritis. Clin Exp Rheumatol 1995; 13: 445-51.
43. Means RT. Clinical application of recombinant erythropoietin in anemia of chronic disease. Hematol Oncol Clin North Am 1994; 8: 933-44.
44. Schreiber S, Howaldt S, Schonoor M, Nikolas S, Bauditz J, Gasche C, et al Recombinant erythropoietin for the treatment anemia in inflammatory bowel disease. N Engl J Med 1996; 334: 616-23.
45. Elliot MJ, Maini RN, Feldmann M. Repeated theraphy with monoclonal antibody to tumor necrosis factor Alpha (cA2) in patients with rheumatoid arthritis Lancet 1994; 344: 1125-7.
46. Weinberg ED. Iron therapy and cancer. Kidney Int 1999; 55: 131-4.